The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non‐small cell lung cancer

• Main Authors: Hailun Xie (Author), Guotian Ruan (Author), Lishuang Wei (Author), Li Deng (Author), Qi Zhang (Author), Yizhong Ge (Author), Mengmeng Song (Author), Xi Zhang (Author), Shiqi Lin (Author), Xiaoyue Liu (Author), Ming Yang (Author), Chunhua Song (Author), Xiaowei Zhang (Author), Hanping Shi (Author)
• Format: Book
• Published: Wiley, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Systemic inflammation, the most representative tumour-host interaction, plays a crucial role in disease progression and prognosis in patients with non‐small cell lung cancer (NSCLC). Few studies have compared the performance of existing haematological systemic inflammation biomar...